Gainers
- Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) shares are up 7 percent after falling 15.6 percent in the regular session.
- Verastem Inc (NASDAQ:VSTM) shares are up 6 percent after announcing the signing of an exclusive license agreement for the development and commercialization of COPIKTRA in China. The company will receive an upfront payment of $15 million and will be eligible for up to $30 million in milestones.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Losers
- Digital Ally, Inc. (NASDAQ:DGLY) shares are down 7 percent after announcing a common stock offering. The size was not disclosed.
- GasLog Partners LP Unit (NYSE:GLOP) shares are down 6 percent. No news was immediately available.
- Cintas Corporation (NASDAQ:CTAS) shares are down 6 percent despite reporting a first-quarter earnings beat. Adjusted earnings came in at $1.93, beating estimates by 13 cents. Sales came in at $1.7 billion, beating estimates by $20 million. The company raised FY19 guidance.
- Nike Inc (NYSE:NKE) shares are down 3 percent despite reporting a first-quarter earnings beat. Earnings came in at 67 cents per share, beating estimates by 5 cents. Sales came in at $9.948 billion, beating estimates by $18 million The company said gross margins increased from 43.7 percent to 44.2 percent in the same quarter of last year. Inventories were $5.2 billion, unchanged from last year.